Skip to main content

Table 7 Linear mixed model results of the MCI and dementia groups stratified by APOE ε4 status

From: Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease

 

MCI group

Dementia group

APOEε4 positive (n = 58)

APOEε4 negative (n = 48)

APOEε4 positive (n = 36)

APOEε4 negative (n = 14)

Effect

Slope (95% CI)

p-value

Slope (95% CI)

p-value

Slope (95% CI)

p-value

Slope (95% CI)

p-value

MMSE

 CSF ApoA1

 − 0.059 (0.302, 0.183)

0.63

0.233 (− 0.024, 0.489)

0.075

 − 1.029 (− 1.950, − 0.108)

0.029

1.078 (− 0.205, 2.361)

0.097

 Plasma ApoA1

 − 0.798 (− 1.258, − 0.339)

 < 0.001

 − 0.474 (− 0.740, − 0.209)

 < 0.001

 − 1.715 (− 3.285, − 0.146)

0.033

 − 0.794 (− 3.923, 2.336)

0.61

 Plasma TG/HDL

 − 0.327 (− 0.562, − 0.093)

0.006

 − 0.044 (− 0.173, 0.084)

0.50

 − 0.559 (− 1.279, 0.162)

0.13

0.960 (− 1.045, 2.965)

0.34

CDR-SB

 CSF ApoA1

0.220 (0.057, 0.383)

0.008

0.076 (− 0.113, 0.264)

0.43

0.137 (− 0.451, 0.725)

0.64

 − 0.474 (− 1.245, 0.297)

0.22

 Plasma ApoA1

0.518 (0.199, 0.838)

0.002

 − 0.032 (− 0.229, 0.164)

0.75

0.656 (− 0.346, 1.658)

0.19

0.729 (− 1.151, 2.609)

0.44

 TG/HDL

0.287 (0.126, 0.448)

 < 0.001

0.057 (− 0.038, 0.152)

0.24

0.580 (0.120, 1.040)

0.014

 − 0.112 (− 1.316, 1.093)

0.85

LM

 CSF ApoA1

0.017 (− 0.156, 0.190)

0.84

0.093 (− 0.163, 0.350)

0.47

0.042 (− 0.282, 0.366)

0.79

0.613 (− 0.008, 1.234)

0.053

 Plasma ApoA1

0.220 (− 0.108, 0.549)

0.19

 − 0.598 (− 0.866, − 0.330)

 < 0.001

0.068 (− 0.479, 0.615)

0.80

 − 2.753 (− 4.268, − 1.239)

< 0.001

 Plasma TG/HDL

0.125 (− 0.044, 0.293)

0.15

0.002 (− 0.127, 0.130)

0.98

0.142 (− 0.117, 0.402)

0.28

 − 0.548 (− 1.518, 0.423)

0.26

  1. MMSE Mini-Mental Status Exam score, CDR-SB Clinical Dementia Rating Scale–Sum of Boxes score, LM Logical memory delayed recall score. Positive slope notes faster progression CDR-SB, negative slope notes faster progression in MMSE and LM